2016
DOI: 10.1016/j.ejmech.2016.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…The antiproliferative activity of these marchantin C analogues revealed that the most potent compounds 40 and 41 (Figure ) showed outstanding antiproliferative effects toward four kinds of cancer cell lines (i.e., HeLa, HT29, k562, and HCC1428), which was significantly superior to that of marchantin C. More importantly, compounds 40 and 41 could effectively inhibit the growth of the paclitaxel-resistant PC-3/Doc cancer cell line. Further biochemistry experiments demonstrated that these two compounds possessed excellent inhibition against tubulin polymerization in the tested HCC1482 cells and could abort the cell cycle of HCC1482 cells at the G2/M phase. , The above-mentioned natural product analogues 39 , 40 , and 41 with the DE scaffold provide several new and promising candidates for the development of novel antitumor agents targeting tubulin.…”
Section: Application Of De Scaffold In Medicinal Chemistrymentioning
confidence: 90%
See 1 more Smart Citation
“…The antiproliferative activity of these marchantin C analogues revealed that the most potent compounds 40 and 41 (Figure ) showed outstanding antiproliferative effects toward four kinds of cancer cell lines (i.e., HeLa, HT29, k562, and HCC1428), which was significantly superior to that of marchantin C. More importantly, compounds 40 and 41 could effectively inhibit the growth of the paclitaxel-resistant PC-3/Doc cancer cell line. Further biochemistry experiments demonstrated that these two compounds possessed excellent inhibition against tubulin polymerization in the tested HCC1482 cells and could abort the cell cycle of HCC1482 cells at the G2/M phase. , The above-mentioned natural product analogues 39 , 40 , and 41 with the DE scaffold provide several new and promising candidates for the development of novel antitumor agents targeting tubulin.…”
Section: Application Of De Scaffold In Medicinal Chemistrymentioning
confidence: 90%
“…Further biochemistry experiments demonstrated that these two compounds possessed excellent inhibition against tubulin polymerization in the tested HCC1482 cells and could abort the cell cycle of HCC1482 cells at the G2/M phase. 57,58 The above-mentioned natural product analogues 39, 40, and 41 with the DE scaffold provide several new and promising candidates for the development of novel antitumor agents targeting tubulin.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Even though, many drugs could be brominated under mild oxidation reagent DMSO and relatively low temperature ( Scheme 10 a) 157 . Lou group used this strategy to brominate Marchantin C, and obtained a series of analogs with anticancer activity 2–6 fold higher 158 . In 2022, Jiao and coworkers made a breakthrough in bromination of electron-deficient aromatic rings.…”
Section: Halogenation Of Bioactive Compoundsmentioning
confidence: 99%